CDK4 and colonic neoplasm: The molecular mechanism studies suggest that CDK2/cyclin E and CDK4/cyclin D are involved in the inhibition of colon cancer cell proliferation by fargesin via p21WAF1/Cip1 and c-Myc, respectively.